Horizon_Logo_B_200.png

Horizon Carrier Screen

ACOG now recommends hemoglobinopathy analysis for all women 

ACOG now recommends hemoglobinopathy analysis for all women, with DNA-based testing following screening through complete blood count and hemoglobin electrophoresis, in their Committee Opinion #691 released in March 2017. DNA confirmation of sickle cell, hemoglobin AS, beta thalassemia carrier status is available through Horizon.

View panel details.

 

Gain greater clarification of alpha thalassemia carrier status

Screening for hemoglobinopathies with Horizon provides clarification of alpha thalassemia carrier status when MCV is low and hemoglobin electrophoresis results are normal.

Screen Shot 2017-05-04 at 12.10.07 PM.png